Madhuri Vusirikala, M.D. is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Hematology-Oncology. She is Medical Director of the Adult National Marrow Donor Program Transplant Program at UT Southwestern, as well as Director of the Allogeneic Stem Cell Transplant Program, and Director of the Inpatient Bone Marrow Transplant Unit.

Dr. Vusirikala received her medical degree from Lady Hardinge Medical College in New Delhi, India, and completed internal medicine residency training at the State University of New York in Syracuse. She then completed advanced training through a fellowship in hematology/oncology at the University of Pittsburgh, and a subsequent fellowship in bone marrow transplant at Vanderbilt University Medical Center.

Certified by the American Board of Internal Medicine in internal medicine, oncology, and hematology, she served on the faculty of Vanderbilt University School of Medicine before joining the UT Southwestern faculty in 2006.

Dr. Vusirikala’s research interests include graft-versus-host disease, malignant hematologic disorders, and survivorship after stem cell transplant.

Her investigations have resulted in many publications in peer-reviewed journals. Additionally, she has presented her findings at scientific conferences throughout the United States and the world.

Dr. Vusirikala is active in several professional societies, including the Texas Medical Association, the Dallas County Medical Society, the American Society of Transplantation and Cellular Therapy, and the American College of Physicians.


Medical School
Lady Hardinge Medical College, India (1991)
Delhi University/Maulana Azad Medical College (1993), Internal Medicine
SUNY Upstate Medical University (1996), Internal Medicine
University of Pittsburgh (1999), Hematology Oncology
Advanced Fellowship
Vanderbilt University Medical Center (2000), Bone Marrow Transplant

Research Interest

  • acute and chronic graft versus host disease
  • acute leukemias
  • allogeneic stem cell transplant in hematologic disorders
  • Other malignant hematologic disorders-lymphomas, MDS, MPD, MF, myeloma
  • survivorship after stem cell transplant


Featured Publications LegendFeatured Publications

Dose-Intensification and Stem Cell Transplantation (SCT) for histologically transformed Low-grade Follicular Non-Hodgkin Lymphoma (NHL): A single center experience
Vusirikala M, Brandt S, Chinratanalab W, Greer JP, Jagasia M, Kassim A, Mineshi S, Morgan DS, Ruffner K, Friedrich SG, Shyr Y, Goodman SA Biol Blood Marrow Transplant 2004 10 192
A phase II trial of high dose chemotherapy and conccurrent rituximab followed by autologous peripheral blood stem cell transplantation for treatment of relapsed CD20 positive B-cell Non-Hodgkin’s Lymphoma
Vusirikala M, Stein RS, Brandt S, Morgan D, Greer J, Jagasia M, Kassim A, Schuening F, Goodman S Biol Blood Marrow Transplant 2002 8 101


Featured Books Legend Featured Books

Professional Associations/Affiliations

  • American Society of Bone Marrow Transplant (2010)
  • American Society of Hematology (1998)